Deciphera Pharma Stock Price, News & Analysis
Company Description
Deciphera Pharma (NASDAQ: DCPH) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $2.2B, ranking #2,073 among all listed U.S. companies by market cap.
DCPH stock has declined 100.0% over the past year. Shares last traded at $25.59.
This page provides a comprehensive overview of DCPH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Deciphera Pharma (DCPH) stock last traded at $25.59. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $2.2B, DCPH is classified as a mid-cap stock with approximately 86.5M shares outstanding.
Latest News
Deciphera Pharma has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, clinical trial, conferences, earnings. View all DCPH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
DCPH Company Profile & Sector Positioning
Deciphera Pharma (DCPH) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.